Levalbuterol HFA MDI

DRUG2 trials

Sponsors

Sumitomo Pharma America, Inc.

Conditions

AsthmaBronchoconstriction

Phase 2

Dose Response Study of Levalbuterol in the Prevention of Exercise Induced Bronchoconstriction Compared to Racemic Albuterol in Pediatric Subjects

CompletedNCT00685347

Sumitomo Pharma America, Inc.Asthma, Bronchoconstriction

Start: 2003-01-31End: 2003-06-30Updated: 2012-02-22

Phase 3

Dose Response Study of Levalbuterol in the Prevention of Exercise Induced Bronchoconstriction Compared to Racemic Albuterol

CompletedNCT00685425

Sumitomo Pharma America, Inc.Asthma, Bronchoconstriction

Start: 2002-10-31End: 2003-03-31Updated: 2012-02-22